Ganser A - Search Results

1

Results of phase I/II trials with recombinant human interleukin-3.

Ganser A, Ottmann OG, Seipelt G, Eder M, Geissler G, Merget R, Maurer A, Falk S, Lindemann A, Herrmann F, et al. Ganser A, et al. Biotechnol Ther. 1991;2(3-4):313-25. Biotechnol Ther. 1991. PMID: 1845133 Review. No abstract available.

2

A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias.

Lübbert M, Oster W, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F. Lübbert M, et al. Among authors: ganser a. Blood. 1992 Oct 15;80(8):2066-73. Blood. 1992. PMID: 1327288 Free article.

3

[Enhanced lymphocyte proliferation in the presence of epidermal cells of HIV-infected patients in vitro].

Kappus RP, Berger S, Thomas CA, Ottmann OG, Ganser A, Stille W, Shah PM. Kappus RP, et al. Among authors: ganser a. Immun Infekt. 1992 Jul;20(3):99-102. Immun Infekt. 1992. PMID: 1354198 German.

4

Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs.

Ganser A, Seipelt G, Eder M, Geissler G, Ottmann OG, Hess U, Hoelzer D. Ganser A, et al. Semin Oncol. 1992 Apr;19(2 Suppl 4):95-101. Semin Oncol. 1992. PMID: 1372766 Review.

5

Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.

Schardt C, Ottmann OG, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ganser a. Leukemia. 1992 May;6(5):370-4. Leukemia. 1992. PMID: 1375695

6

Interleukin-3 in the treatment of myelodysplastic syndromes.

Ganser A, Ottmann OG, Hoelzer D. Ganser A, et al. Int J Clin Lab Res. 1992;22(3):125-8. doi: 10.1007/BF02591411. Int J Clin Lab Res. 1992. PMID: 1520908 Review.

7

Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

Hess U, Ganser A, Schnürch HG, Seipelt G, Ottmann OG, Falk S, Schulz G, Hoelzer D. Hess U, et al. Among authors: ganser a. Br J Haematol. 1992 Feb;80(2):254-6. doi: 10.1111/j.1365-2141.1992.tb08910.x. Br J Haematol. 1992. PMID: 1550786 No abstract available.

8

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.

Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, et al. Ganser A, et al. Blood. 1992 May 15;79(10):2583-91. Blood. 1992. PMID: 1586711 Free article. Clinical Trial.

9

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Among authors: ganser a. Blood. 1992 Jun 15;79(12):3274-84. Blood. 1992. PMID: 1596568 Free article.

10

Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individuals.

Geissler RG, Ottmann OG, Kojouharoff G, Reutzel P, Eder M, Hoelzer D, Ganser A. Geissler RG, et al. Among authors: ganser a. AIDS Res Hum Retroviruses. 1992 Apr;8(4):521-5. doi: 10.1089/aid.1992.8.521. AIDS Res Hum Retroviruses. 1992. PMID: 1599759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

885 results

Search Page

Filters